US SB658 | 2019-2020 | 116th Congress
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on March 5 2019 - 25% progression, died in committee
Action: 2020-05-19 - S.Amdt.1588 Referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 5 2019 - 25% progression, died in committee
Action: 2020-05-19 - S.Amdt.1588 Referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to provide for an accelerated approval pathway for certain drugs that are authorized to be lawfully marketed in other countries.
Title
ADAPT Act Accelerated Drug Approval for Prescription Therapies Act
Sponsors
Sen. Mike Braun [R-IN] |
History
Date | Chamber | Action |
---|---|---|
2020-05-19 | Senate | S.Amdt.1588 Referred to the Committee on Health, Education, Labor, and Pensions. |
2019-03-05 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Subjects
Drug safety, medical device, and laboratory regulation
Health
Marketing and advertising
Prescription drugs
Health
Marketing and advertising
Prescription drugs
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/senate-bill/658/all-info |
Text | https://www.congress.gov/116/bills/s658/BILLS-116s658is.pdf |